382 related articles for article (PubMed ID: 1671029)
41. Clinical experience with intravenous fenoldopam.
Holcslaw TL; Beck TR
Am J Hypertens; 1990 Jun; 3(6 Pt 2):120S-125S. PubMed ID: 1974440
[TBL] [Abstract][Full Text] [Related]
42. Functional ontogeny of pulmonary vascular DA1 dopamine receptors in the isolated perfused rabbit lung.
Polak MJ; Taylor DA
Pediatr Res; 1994 Feb; 35(2):228-32. PubMed ID: 7909367
[TBL] [Abstract][Full Text] [Related]
43. The pharmacology of fenoldopam.
Nichols AJ; Ruffolo RR; Brooks DP
Am J Hypertens; 1990 Jun; 3(6 Pt 2):116S-119S. PubMed ID: 1974439
[TBL] [Abstract][Full Text] [Related]
44. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
Iwao T; Toyonaga A; Ikegami M; Sugawara H; Sumino M; Takagi K; Oho K; Sakaki M; Ohkubo K; Inoue R
Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
[TBL] [Abstract][Full Text] [Related]
45. Hemodynamic and sympathetic responses to human atrial natriuretic peptide infusion in patients with cirrhosis.
Brenard R; Moreau R; Pussard E; Champigneulle B; Gaudin C; Hadengue A; Braillon A; Lebrec D
J Hepatol; 1992 Mar; 14(2-3):347-56. PubMed ID: 1386858
[TBL] [Abstract][Full Text] [Related]
46. DA1 dopamine receptors in renal cortical collecting duct.
Ohbu K; Felder RA
Am J Physiol; 1991 Nov; 261(5 Pt 2):F890-5. PubMed ID: 1683170
[TBL] [Abstract][Full Text] [Related]
47. Effect of dopamine on renal blood flow, prostaglandins, renin and electrolyte excretion in normal and hypertensive humans.
Horton R; Bughi S; Jost-Vu E; Antonipillai I; Nadler J
Am J Hypertens; 1990 Jun; 3(6 Pt 2):108S-111S. PubMed ID: 1974438
[TBL] [Abstract][Full Text] [Related]
48. Portal and systemic hemodynamics and humoral factors in cirrhosis with and without ascites.
Hayes PC; Cumming AD; Craig KJ; Watson M; Bouchier IA
Am J Gastroenterol; 1992 Oct; 87(10):1433-8. PubMed ID: 1415100
[TBL] [Abstract][Full Text] [Related]
49. Fenoldopam, but not nitroprusside, improves renal function in severely hypertensive patients with impaired renal function.
Shusterman NH; Elliott WJ; White WB
Am J Med; 1993 Aug; 95(2):161-8. PubMed ID: 8102835
[TBL] [Abstract][Full Text] [Related]
50. Haemodynamic and pharmacokinetic study of intravenous fenoldopam in patients with hepatic cirrhosis.
Vlavianos P; Polson RJ; Settin A; Glover J; Westaby D; Williams R
Br J Clin Pharmacol; 1990 Jan; 29(1):19-25. PubMed ID: 1967532
[TBL] [Abstract][Full Text] [Related]
51. Long-term sympathetic and hemodynamic responses to clonidine in patients with cirrhosis and ascites.
Roulot D; Moreau R; Gaudin C; Bacq Y; Braillon A; Hadengue A; Frohly P; Lebrec D
Gastroenterology; 1992 Apr; 102(4 Pt 1):1309-18. PubMed ID: 1551536
[TBL] [Abstract][Full Text] [Related]
52. Effect of fenoldopam on preconstricted isolated salt-perfused rat lungs.
Polak MJ; Knight ME; Gause GE; Bucciarelli RL; Drummond W
J Appl Physiol (1985); 1989 Sep; 67(3):1076-80. PubMed ID: 2571605
[TBL] [Abstract][Full Text] [Related]
53. The dopamine DA-1 receptor agonist fenoldopam enhances amino-acid-induced hyperemia in dogs.
Brooks DP; DePalma D
Pharmacology; 1993 Jul; 47(1):43-9. PubMed ID: 8101655
[TBL] [Abstract][Full Text] [Related]
54. [New dopamine agonists in cardiovascular therapy].
Girbes AR; Van Veldhuisen DJ; Smit AJ
Presse Med; 1992 Aug 29-Sep 5; 21(27):1287-91. PubMed ID: 1359528
[TBL] [Abstract][Full Text] [Related]
55. Effects of nitric oxide inhibition by methylene blue in cirrhotic patients with ascites.
Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Christos P; Paraskevi K; Konstantinos P; Katsaraki A; Tsianos EV
Dig Dis Sci; 2005 Oct; 50(10):1771-7. PubMed ID: 16187171
[TBL] [Abstract][Full Text] [Related]
56. Midodrine in patients with cirrhosis and refractory or recurrent ascites: a randomized pilot study.
Singh V; Dhungana SP; Singh B; Vijayverghia R; Nain CK; Sharma N; Bhalla A; Gupta PK
J Hepatol; 2012 Feb; 56(2):348-54. PubMed ID: 21749847
[TBL] [Abstract][Full Text] [Related]
57. Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertension.
Elliott WJ; Weber RR; Nelson KS; Oliner CM; Fumo MT; Gretler DD; McCray GR; Murphy MB
Circulation; 1990 Mar; 81(3):970-7. PubMed ID: 1968368
[TBL] [Abstract][Full Text] [Related]
58. Systemic and splanchnic oxygen supply-demand relationship with fenoldopam, dopamine and noradrenaline in sheep.
Schiffer ER; Schwieger IM; Gosteli P; Poinsot O; Mentha G; Morel DR
Eur J Pharmacol; 1995 Nov; 286(1):49-60. PubMed ID: 8566151
[TBL] [Abstract][Full Text] [Related]
59. The renal and hemodynamic effects of the peritoneovenous shunt for intractable hepatic ascites.
Blendis LM; Greig PD; Langer B; Baigrie RS; Ruse J; Taylor BR
Gastroenterology; 1979 Aug; 77(2):250-7. PubMed ID: 447039
[TBL] [Abstract][Full Text] [Related]
60. Effects of captopril on renal functions, renal and portal hemodynamics in patients with cirrhosis.
Tsai YT; Lin HC; Lee FY; Hou MC; Wang SS; Lee SD
Proc Natl Sci Counc Repub China B; 1996 Apr; 20(2):44-50. PubMed ID: 8931343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
